FAP: The Next Billion Dollar Nuclear Theranostics Target?
Author:
Publisher
Society of Nuclear Medicine
Subject
Radiology, Nuclear Medicine and imaging
Reference31 articles.
1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
2. [177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study;Hofman;Lancet Oncol.,2018
3. Nuclear Medicine and Wall Street: An Evolving Relationship
4. Turning foes to friends: targeting cancer-associated fibroblasts
5. Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts;Frontiers in Oncology;2024-08-30
2. Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention;Journal of Medicinal Chemistry;2024-07-30
3. Permutational Encoding Strategy Accelerates HIT Validation from Single-Stranded DNA-Encoded Libraries;Bioconjugate Chemistry;2024-07-04
4. Identifying New Therapeutic Targets in Epithelial Ovarian Cancer;2024-06-26
5. Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types;Journal of Medicinal Chemistry;2024-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3